Back
BioHarvest Sciences Quote, Financials, Valuation and Earnings
The dark truth about AI
Click here to learn more...
Buy
55
BHSC.CX
BioHarvest Sciences
Last Price:
8.92
Seasonality Move:
24.25%
7 Day Trial
ALL ACCESS PASS
$
7
Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!
Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)BioHarvest Sciences Price Quote
$8.92
BioHarvest Sciences Key Stats
Buy
55
BioHarvest Sciences (BHSC.CX)
is a Buy
Day range:
$8.50 - $8.92
52-week range:
$6.24 - $10.50
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
4.49
P/B ratio:
27.64%
Volume:
2K
Avg. volume:
7.7K
1-year change:
18.54%
Market cap:
$154.6M
Revenue:
$17.1M
EPS:
$-1.8
How Much Does BioHarvest Sciences Make?
-
How Much Are BioHarvest Sciences's Sales Annually?
BHSC.CX Revenues are $17.1M -
How Much Profit Does BioHarvest Sciences's Make A Year?
BHSC.CX net income is -$17M
Is BioHarvest Sciences Growing As A Company?
-
What Is BioHarvest Sciences's Growth Rate Quarterly?
Quarterly YoY revenue growth is 1.05% -
What Is BioHarvest Sciences's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
BioHarvest Sciences Stock Price Performance
-
Did BioHarvest Sciences Stock Go Up Last Month?
BioHarvest Sciences share price went up by 6.19% last month -
Did BHSC.CX's Share Price Rise Over The Last Year?
BHSC.CX share price rose by 18.54% over the past 1 year
What Is BioHarvest Sciences 52-Week High & Low?
-
What Is BioHarvest Sciences’s 52-Week High Share Price?
BioHarvest Sciences has traded as high as $10.50 over the past 52 weeks -
What Is BioHarvest Sciences’s 52-Week Low Share Price?
BioHarvest Sciences has traded as low as $6.24 over the past 52 weeks
BioHarvest Sciences Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy BioHarvest Sciences?
-
How Much Debt Does BioHarvest Sciences Have?
Total long term debt quarterly is $1.6M -
How Much Cash Does BioHarvest Sciences Have?
Cash and short term investments quarterly total is $3.7M -
What Is BioHarvest Sciences’s Book Value Per Share?
Book value per share is 0.32
Is BioHarvest Sciences Cash Flow Positive?
-
What Is BHSC.CX Cash Flow From Operations?
Cash flow from operations (TTM) is -$9.9M -
What Is BioHarvest Sciences’s Cash Flow From Financing?
Cash flow from financing (TTM) is $15.4M -
What Is BioHarvest Sciences’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$4M
BioHarvest Sciences Return On Invested Capital
-
Is Management Doing A Good Job?
BHSC.CX return on invested capital is -332.9% -
What Is BioHarvest Sciences Return On Assets?
ROA measures how assets are converting to revenues and is -94.34% -
What Is BHSC.CX Return On Equity?
ROE is a measure of profitability and is 0%
BioHarvest Sciences Earnings Date & Stock Price
-
What Is BioHarvest Sciences's Stock Price Today?
A single share of BHSC.CX can be purchased today for 8.92 -
What Is BioHarvest Sciences’s Stock Symbol?
BioHarvest Sciences trades on the cnsx under the ticker symbol: BHSC.CX -
When Is BioHarvest Sciences’s Next Earnings Date?
The next quarterly earnings date for BioHarvest Sciences is scheduled on December 15, 2024 -
When Is BHSC.CX's next ex-dividend date?
BioHarvest Sciences's next ex-dividend date is December 15, 2024 -
How To Buy BioHarvest Sciences Stock?
You can buy BioHarvest Sciences shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
BioHarvest Sciences Competitors
-
Who Are BioHarvest Sciences's Competitors?
Below is a list of companies who compete with BioHarvest Sciences or are related in some way:
BioHarvest Sciences Dividend Yield
-
What Is BHSC.CX Dividend Yield?
BioHarvest Sciences’s dividend yield currently is 0% -
What Is BioHarvest Sciences’s Payout Ratio?
BioHarvest Sciences’s payout ratio is 0% -
When Did BioHarvest Sciences Last Pay A Dividend?
The latest dividend pay date is December 15, 2024 -
What Is BioHarvest Sciences’s Dividend Per Share?
BioHarvest Sciences pays a dividend of $0.00 per share
BioHarvest Sciences Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 0% |
| Revenue: | 105.26% | -0.2% |
Analyst Recommendations
| Buy Recommendations: | 0 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 0.00 |
| Downside from Last Price: | -100% |
Major Shareholders
Data Unavailable